Johnson & Johnson Xarelto Lawsuits
Bayer and Johnson & Johnson Downplayed Xarelto Risks, Suits Allege
July 14, 2017
Two lawsuits filed in New York allege that Bayer HealthCare Pharmaceuticals and Johnson & Johnson subsidiary Janssen Pharmaceuticals understated and misrepresented the health risks associated with their blood thinner Xarelto.
Two of the plaintiffs, Thomas Walsh and Joseph Roman, allege that their Xarelto use directly caused the “life-threatening bleeding” that they suffered, and that the drug’s manufacturers concealed their knowledge of Xarelto’s dangerous effects, which had been caused by a lack of clinical trials.
The suits allege that the $11 million direct-to-consumer marketing campaign overstated Xarelto’s effectiveness in preventing strokes and embolisms.
The U.S. Food and Drug Administration has received thousands of complaints about Xarelto, most of which pertain to the drug’s alleged role in causing severe hemorrhaging.
The claims made in the cases include negligence, breach of warranty, product liability, fraudulent concealment, negligent misrepresentation, and others.
Bayer and Janssen are also involved in separate Multi-District Litigation involving Xarelto. The companies have won two trials in that legal action; a third is pending.
If your health has been threatened by Xarelto or any other prescription drug, you may have a case. Contact the expert attorneys at TheLawFirm.com today.
TheLawFirm.com’s award winning lawyers have been featured in over 50 radio and television interviews including:
Real lawyers, real results!
no recovery, no fee!